ATI-22107

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameATI-22107
Drug Alias NamePDE 3 inhibitor/calcium channel blocker (Artesian)PDE 3 inhibitor/calcium channel blocker (Cardiome Pharma)CRPM program (Cardiome Pharma)congestive heart failure therapy (Artesian)CRPM program (Artesian) +[8] 
ClassificationSmall molecules
Mechanisms of ActionPhosphodiesterase 3 inhibitorsVoltage-gated L-type calcium channel blockers
TargetsPhosphodiesterase 3Voltage-gated L-type calcium channel
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArtesian Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArtesian Therapeutics IncCorrevio Pharma Corp
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A